[go: up one dir, main page]

NO20000484D0 - Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel - Google Patents

Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Info

Publication number
NO20000484D0
NO20000484D0 NO20000484A NO20000484A NO20000484D0 NO 20000484 D0 NO20000484 D0 NO 20000484D0 NO 20000484 A NO20000484 A NO 20000484A NO 20000484 A NO20000484 A NO 20000484A NO 20000484 D0 NO20000484 D0 NO 20000484D0
Authority
NO
Norway
Prior art keywords
crystalline
füä1
ethylü
dibenzoäb
hydroxyethoxy
Prior art date
Application number
NO20000484A
Other languages
English (en)
Other versions
NO20000484L (no
Inventor
Evan William Snape
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO20000484D0 publication Critical patent/NO20000484D0/no
Publication of NO20000484L publication Critical patent/NO20000484L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
NO20000484A 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel NO20000484L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process
PCT/GB1998/002260 WO1999006381A1 (en) 1997-08-01 1998-07-28 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent

Publications (2)

Publication Number Publication Date
NO20000484D0 true NO20000484D0 (no) 2000-01-31
NO20000484L NO20000484L (no) 2000-03-16

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000484A NO20000484L (no) 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Country Status (31)

Country Link
US (2) US6372734B1 (no)
EP (2) EP1000043B1 (no)
JP (2) JP2001512109A (no)
KR (1) KR20010022241A (no)
CN (1) CN1125058C (no)
AT (2) ATE444959T1 (no)
AU (1) AU739255B2 (no)
BG (1) BG64796B1 (no)
BR (1) BR9811061A (no)
CA (1) CA2295792C (no)
CY (2) CY2200162T2 (no)
CZ (1) CZ299225B6 (no)
DE (4) DE05011169T1 (no)
EE (1) EE04550B1 (no)
ES (2) ES2296575T3 (no)
GB (2) GB9716161D0 (no)
HU (1) HU228620B1 (no)
ID (1) ID24219A (no)
IL (1) IL133618A (no)
MY (1) MY120999A (no)
NO (1) NO20000484L (no)
NZ (1) NZ501914A (no)
PL (1) PL338384A1 (no)
PT (2) PT1000043E (no)
RU (1) RU2224754C2 (no)
SI (2) SI1589008T1 (no)
SK (1) SK287145B6 (no)
TR (1) TR200000848T2 (no)
TW (1) TW533207B (no)
WO (1) WO1999006381A1 (no)
ZA (1) ZA986904B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2000141A1 (en) * 2002-03-20 2008-12-10 Teva Pharmaceutical Industries Ltd. Methods for preparing crystalline quetiapine hemifumarate
WO2004076431A1 (en) * 2003-02-22 2004-09-10 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
AU2003216705A1 (en) * 2003-03-03 2004-09-28 Hetero Drugs Limited Novel polymorphs of quetiapine fumarate
WO2004089957A1 (en) * 2003-04-07 2004-10-21 Hetero Drugs Limited A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
EP1869007A1 (en) 2005-04-14 2007-12-26 Teva Pharmaceutical Industries Ltd Process for preparing quetiapine fumarate
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
US8044038B2 (en) * 2005-09-30 2011-10-25 Fermion Oy Crystallization process of quetiapine hemifumarate
US8044039B2 (en) 2005-10-28 2011-10-25 Fermion Oy Quetiapine hemifumarate purification by crystallization
JP2009516705A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 塩の形態
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
JP2009516708A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 液体製剤
JP2009516706A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 結晶形
EP1951693A4 (en) * 2005-11-18 2012-05-30 Astrazeneca Ab SOLID FORMULATIONS
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives
DE602007009036D1 (de) 2007-02-14 2010-10-21 Lesvi Laboratorios Sl Pharmazeutische Zusammensetzungen mit Quetiapinfumarat
JP2009529062A (ja) * 2007-03-29 2009-08-13 テバ ファーマシューティカル インダストリーズ リミティド フマル酸クエチアピンを調製するための改良法
WO2009004480A2 (en) * 2007-05-07 2009-01-08 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
CA2706903C (en) * 2007-12-05 2015-11-17 Henricus Jacobus Maria Gijsen Dibenzoazepine and dibenzooxazepine trpa1 agonists
DE202009018024U1 (de) 2008-08-01 2010-12-09 Krka Tovarna Zdravil, D.D., Novo Mesto Quetiapin-Zusammensetzung
WO2010033270A1 (en) * 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
EP2403841A1 (en) 2009-03-04 2012-01-11 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
WO2013024072A1 (en) 2011-08-12 2013-02-21 Qiagen Gmbh Method for isolating nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
EP1589008B1 (en) 2011-01-19
GB9716161D0 (en) 1997-10-08
TW533207B (en) 2003-05-21
US20020147186A1 (en) 2002-10-10
HUP0002663A2 (hu) 2001-09-28
EP1589008A1 (en) 2005-10-26
JP2001512109A (ja) 2001-08-21
RU2224754C2 (ru) 2004-02-27
ID24219A (id) 2000-07-13
NZ501914A (en) 2001-09-28
EE200000062A (et) 2000-10-16
ATE496037T1 (de) 2011-02-15
CY2200162T2 (el) 2010-07-28
HK1029992A1 (en) 2001-04-20
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
GB9814882D0 (en) 1998-09-09
TR200000848T2 (tr) 2000-08-21
BR9811061A (pt) 2000-09-19
CA2295792C (en) 2007-04-17
DE69842104D1 (de) 2011-03-03
PT1000043E (pt) 2009-11-30
ZA986904B (en) 1999-02-01
HUP0002663A3 (en) 2001-10-29
HK1081962A1 (en) 2006-05-26
NO20000484L (no) 2000-03-16
SK287145B6 (sk) 2010-01-07
JP2009102345A (ja) 2009-05-14
CZ299225B6 (cs) 2008-05-21
CN1125058C (zh) 2003-10-22
DE98936529T1 (de) 2008-11-20
EP1000043A1 (en) 2000-05-17
SK1302000A3 (en) 2000-06-12
ES2296568T1 (es) 2008-05-01
AU739255B2 (en) 2001-10-04
ES2296575T1 (es) 2008-05-01
BG104176A (en) 2000-08-31
ATE444959T1 (de) 2009-10-15
PL338384A1 (en) 2000-10-23
CA2295792A1 (en) 1999-02-11
ES2296568T3 (es) 2011-05-06
WO1999006381A1 (en) 1999-02-11
PT1589008E (pt) 2011-03-23
KR20010022241A (ko) 2001-03-15
EE04550B1 (et) 2005-10-17
DE05011169T1 (de) 2008-11-06
BG64796B1 (bg) 2006-04-28
CN1265101A (zh) 2000-08-30
EP1000043B1 (en) 2009-10-07
DE69841216D1 (de) 2009-11-19
AU8549898A (en) 1999-02-22
MY120999A (en) 2005-12-30
US6372734B1 (en) 2002-04-16
CY2200161T2 (el) 2010-07-28
SI1589008T1 (sl) 2011-04-29
CZ2000341A3 (cs) 2000-05-17
ES2296575T3 (es) 2010-02-05
HU228620B1 (en) 2013-04-29
SI1000043T1 (sl) 2010-01-29

Similar Documents

Publication Publication Date Title
NO20000484D0 (no) Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
ES2182079T3 (es) Composiciones farmaceuticas de liberacion sostenida que contienen un derivado de dibenzotiazepina.
AU2001295926A1 (en) Process for producign optically active ethyl
NO931534L (no) Sulfonylbenzylsubstituerte benzo- og pyridopyridoner
AU3696197A (en) Process for the recovery of crystalline beta-carotene from natural source
FI962639A0 (fi) Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina
AU4009497A (en) Substituted pyrazolyl-pyrazole derivatives, process for their preparation nd their use as agents with a herbicidal effect
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
DK1075471T3 (da) Idolylderivater som serotonerge midler
ES2091285T3 (es) 2-hidroxi-1,2,3-propanotricarboxilato de 3-((5-metil-2-furanil)-metil)-n-(4-piperidinil)-3h-imidazo-(4,5-b)-piridin-2-amina.
NO993812D0 (no) (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler
FI980947L (fi) Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi
AU7177496A (en) Piperidinylethylamide derivatives as serotonergic agents
PT1019521E (pt) Um metodo para a biotransformacao de compostos de colchicona nos derivados de 3-glicosil correspondentes
DK0789658T3 (da) Styreindretning til at opnå optimal anvendelse af den energi, der frembringes af et fartøjs hovedenergikilde
AU7641291A (en) Composition for disinfecting water by the electrochlorination process and use of this composition
AU7379794A (en) Aza-5,5-fused heterocyclic acids as leukotriene antagonists
DK0980383T3 (da) Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener
AU2002339219A1 (en) Improved process for the preparation of optically active phenoxazine derivatives as antidiabetic agents
IT9022077A0 (it) Procedimento per il recupero dei residui stirenici solforati.
IT236181Y1 (it) Punta perfezionata per chirurgia oculistica,in particolare per larimozione della cataratta
SE9602418D0 (sv) Process for the preparation of organic salts of N'N-diacetylcystine